All stories tagged :

Sample Category Title

China’s time-honored commercial port city Wenzhou to facilitate dialogue between East...

admin
People

$86.8 Million Lactation Massager Market Analysis & Forecast, 2034: Featuring Strategic...

admin
People

Back-to-Back Super Bowl Celebration Continues as Jostens Presents the Kansas City...

admin
People

Hunt’s Kitchen & Design: The Scottsdale Cabinet Experts Elevating Customer Experience...

admin
Pr Newswire

ElmediX Plans Series A Round Based on Strong Signals in a...

admin
Pr Newswire

Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024...

admin
Pr Newswire

Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its...

admin
Pr Newswire

ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with...

admin
Pr Newswire

Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among...

admin
Pr Newswire

SLB and Aker Carbon Capture announce closing of carbon capture joint...

admin
Pr Newswire

Waydoo Flyer EVO: The Future of Efoiling

admin

Featured

Pr Newswire

Harrow Announces Closing of Acquisition of Melt Pharmaceuticals

admin
Pr Newswire

Can-Fite: 9-Year Survival with Complete Cure in an Advanced Liver Cancer...

admin
Pr Newswire

Aiomics Supports Independent Research at Charité to Advance Evidence-Based Clinical Documentation

admin
Pr Newswire

The Medical Stories in the War: the Spirit of Internationalism with...

admin
admin

Harrow Announces Closing of Acquisition of Melt Pharmaceuticals

NASHVILLE, Tenn., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that it has completed the acquisition of Melt Pharmaceuticals, Inc. (Melt), a clinical-stage pharmaceutical company pioneering non-opioid, non-IV therapies for sedation for medical...